Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC, et al. (July 2009). "Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial". American Journal of Surgery. 198 (1): 83–91. doi:10.1016/j.amjsurg.2008.09.016. PMID19268900.
Polgár C, Major T (February 2009). "Current status and perspectives of brachytherapy for breast cancer". International Journal of Clinical Oncology. 14 (1): 7–24. doi:10.1007/s10147-008-0867-y. PMID19225919. S2CID20971836.
Vaidya JS, Baum M, Tobias JS, Massarut S, Wenz F, Murphy O, et al. (December 2006). "Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost". International Journal of Radiation Oncology, Biology, Physics. 66 (5): 1335–8. doi:10.1016/j.ijrobp.2006.07.1378. PMID17084562.
Coelingh Bennink HJ, Verhoeven C, Dutman AE, Thijssen J (January 2017). "The use of high-dose estrogens for the treatment of breast cancer". Maturitas. 95: 11–23. doi:10.1016/j.maturitas.2016.10.010. PMID27889048.
Palmieri C, Patten DK, Januszewski A, Zucchini G, Howell SJ (January 2014). "Breast cancer: current and future endocrine therapies". Mol. Cell. Endocrinol. 382 (1): 695–723. doi:10.1016/j.mce.2013.08.001. PMID23933149.
Green RB, Sethi RS, Lindner HH (July 1964). "Treatment of advanced carcinoma of the breast: Progress in therapy during the past decade". Am. J. Surg. 108: 107–21. doi:10.1016/0002-9610(64)90094-7. PMID14182428.
Van Winkle, Walton (1949). "Council on Pharmacy and Chemistry. Estrogens and Androgens in Mammary Cancer". JAMA: The Journal of the American Medical Association. 140 (15): 1214. doi:10.1001/jama.1949.02900500022007. ISSN0098-7484.
Committee on Research, AMA (1960). "Androgens and estrogens in the treatment of disseminated mammary carcinoma. Retrospective study of nine hundred forty-four patients". Journal of the American Medical Association. 172 (12): 1271. doi:10.1001/jama.1960.03020120049010. ISSN0002-9955.
McNeely ML, Campbell K, Ospina M, Rowe BH, Dabbs K, Klassen TP, et al. (June 2010). "Exercise interventions for upper-limb dysfunction due to breast cancer treatment". The Cochrane Database of Systematic Reviews (6): CD005211. doi:10.1002/14651858.CD005211.pub2. PMID20556760.
Yashar CM, Blair S, Wallace A, Scanderbeg D (1 October 2009). "Initial clinical experience with the Strut-Adjusted Volume Implant brachytherapy applicator for accelerated partial breast irradiation". Brachytherapy. 8 (4): 367–72. doi:10.1016/j.brachy.2009.03.190. PMID19744892.
Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC, et al. (July 2009). "Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial". American Journal of Surgery. 198 (1): 83–91. doi:10.1016/j.amjsurg.2008.09.016. PMID19268900.
Polgár C, Major T (February 2009). "Current status and perspectives of brachytherapy for breast cancer". International Journal of Clinical Oncology. 14 (1): 7–24. doi:10.1007/s10147-008-0867-y. PMID19225919. S2CID20971836.
Vaidya JS, Baum M, Tobias JS, Massarut S, Wenz F, Murphy O, et al. (December 2006). "Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost". International Journal of Radiation Oncology, Biology, Physics. 66 (5): 1335–8. doi:10.1016/j.ijrobp.2006.07.1378. PMID17084562.
Coelingh Bennink HJ, Verhoeven C, Dutman AE, Thijssen J (January 2017). "The use of high-dose estrogens for the treatment of breast cancer". Maturitas. 95: 11–23. doi:10.1016/j.maturitas.2016.10.010. PMID27889048.
Palmieri C, Patten DK, Januszewski A, Zucchini G, Howell SJ (January 2014). "Breast cancer: current and future endocrine therapies". Mol. Cell. Endocrinol. 382 (1): 695–723. doi:10.1016/j.mce.2013.08.001. PMID23933149.
Green RB, Sethi RS, Lindner HH (July 1964). "Treatment of advanced carcinoma of the breast: Progress in therapy during the past decade". Am. J. Surg. 108: 107–21. doi:10.1016/0002-9610(64)90094-7. PMID14182428.
Ostrowski MJ, Jackson AW (1979). "Polyestradiol phosphate: a preliminary evaluation of its effect on breast carcinoma". Cancer Treat Rep. 63 (11–12): 1803–7. PMID393380.
McNeely ML, Campbell K, Ospina M, Rowe BH, Dabbs K, Klassen TP, et al. (June 2010). "Exercise interventions for upper-limb dysfunction due to breast cancer treatment". The Cochrane Database of Systematic Reviews (6): CD005211. doi:10.1002/14651858.CD005211.pub2. PMID20556760.
Yashar CM, Blair S, Wallace A, Scanderbeg D (1 October 2009). "Initial clinical experience with the Strut-Adjusted Volume Implant brachytherapy applicator for accelerated partial breast irradiation". Brachytherapy. 8 (4): 367–72. doi:10.1016/j.brachy.2009.03.190. PMID19744892.
For example National Prescribing Service NPS MedicineWise "Phytoestrogens for menopausal hot flushes". Archived from the original on 26 August 2014. Retrieved 24 August 2014. | Published in Health News and Evidence 14 July 2014 | retrieved 25 August 2014
Polgár C, Major T (February 2009). "Current status and perspectives of brachytherapy for breast cancer". International Journal of Clinical Oncology. 14 (1): 7–24. doi:10.1007/s10147-008-0867-y. PMID19225919. S2CID20971836.
For example National Prescribing Service NPS MedicineWise "Phytoestrogens for menopausal hot flushes". Archived from the original on 26 August 2014. Retrieved 24 August 2014. | Published in Health News and Evidence 14 July 2014 | retrieved 25 August 2014
Van Winkle, Walton (1949). "Council on Pharmacy and Chemistry. Estrogens and Androgens in Mammary Cancer". JAMA: The Journal of the American Medical Association. 140 (15): 1214. doi:10.1001/jama.1949.02900500022007. ISSN0098-7484.
Committee on Research, AMA (1960). "Androgens and estrogens in the treatment of disseminated mammary carcinoma. Retrospective study of nine hundred forty-four patients". Journal of the American Medical Association. 172 (12): 1271. doi:10.1001/jama.1960.03020120049010. ISSN0002-9955.